-

Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

SALT LAKE CITY--(BUSINESS WIRE)--Spectrum Solutions®, saliva diagnostic biotech leader, today announced the official release of a new saliva diagnostic testing innovation, SimplyPERIO™. As advances in science continue to focus on the mouth-body connection and its direct link to systemic disease, SimplyPERIO™ fills a testing void by delivering more intelligent health measures with real clinical relevance using 16 oral targets from a single patient sample.

Gum disease, also called periodontal disease, is one of the most undiagnosed and untreated diseases, but has some of the highest negative impacts on many bodily systems and functions. In addition, gum disease decreases a person’s ability to fight infection and inflammation.

SimplyPERIO™ uses a proprietary molecular technology to test for and measure periodontal bacteria, caries, fungal and viral targets all for one affordable cost. Understanding treatment success is often influenced by host immunity and host response, this unique, highly sensitive and highly specific saliva test offers Providers the real opportunity to elevate patient care with the most complete oral health picture.

“We are using science to make saliva diagnostics simple for both Patients and Providers. SimplyPERIO™ testing is not only pain-free it takes less than 30 seconds for a patient to collect their own sample,” said Dr. David Vigerust, PhD, Chief Science Officer at Spectrum Solutions. “In addition, our CAP accredited laboratory delivers Providers the independent, 3rd party results necessary for intelligent, data-supported patient conversations about stopping and even reversing their disease and systemic risks.”

In the U.S., numbers illustrate that 80% of individuals over 35 have a form of gum disease. Gingivitis, periodontitis and peri-implantitis are all forms of gum disease. These numbers demonstrate that for the vast majority, there may be dangerous and damaging periodontal disease pathogens hiding that can't be identified with a perio-probe or visual exam during regular semi-annual cleanings. Gone unchecked, these harmful oral bacteria and toxins are allowed to sit and accumulate inside the mouth. From inside the mouth these microorganisms move freely to and through the bloodstream with far reaching and catastrophic effects on the heart, arteries, central nervous system and more.

The SimplyPERIO™ patented blue buffer solution located inside the collection device’s cap stabilizes saliva samples at room temperature eliminating any special post-collection storage or shipping requirements. Easily deposit one at a time, supporting at-home patient testing for follow-up and treatment monitoring, or gather an entire day’s worth of in-office collections into the USPS postage-paid return box for mailing samples back to the lab for processing.

ABOUT SPECTRUM SOLUTIONS®

Headquartered in Salt Lake City, Utah, Spectrum Solutions is dedicated to empowering complete wellness and bridging the gap between science and innovative healthcare solutions. Our stand-alone and fully integrated test-to-treat solutions support molecular diagnostics and DTC testing applications, advancing product development and accelerating go-to-market applications. Our single-source, end-to-end capabilities include a CAP accredited molecular diagnostic laboratory, onsite compounding pharmacy, product development, manufacturing and fulfillment. SimplyTest® and Spectrum Solutions® are registered trademarks of Spectrum Solution, LLC. For more information, please visit spectrumsolution.com or simplytest.com.

Contacts

Media Contact
Tim Rush
Springboard5
801-208-1100
tim.rush@springboard5.com

Spectrum Solutions


Release Summary
Spectrum Solutions®, saliva diagnostic biotech leader, is announcing the official release of a new saliva diagnostic testing innovation, SimplyPERIO
Release Versions

Contacts

Media Contact
Tim Rush
Springboard5
801-208-1100
tim.rush@springboard5.com

Social Media Profiles
More News From Spectrum Solutions

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

SALT LAKE CITY--(BUSINESS WIRE)--Spectrum Solutions® and its owned corporations, Alimetrix, Inc., and Microarrays, Inc., today announced the appointment of Bill Phillips as the company’s new chief executive officer, replacing Stephen J. Fanning, who successfully served as Spectrum’s CEO for over four years. Phillips was a founder of Spectrum Solutions and prior to his promotion to CEO, he served as the company’s Chief Operating Officer where he was recognized for his outstanding performance, st...

Knobbe Martens Secures Complete Victory for Spectrum Solutions in Covid-19 Testing PTAB Dispute

IRVINE, Calif.--(BUSINESS WIRE)--A team from Knobbe Martens led by Ali Razai secured a decisive, complete and unprecedented victory for Spectrum Solutions, LLC in inter partes review (IPR) challenges of five separate patents owned by Longhorn Vaccines & Diagnostics. In an Order granting Spectrum’s Motion for Sanctions, the U.S. Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) found that Longhorn “committed an egregious abuse of the PTAB process” during the IPR proc...

Spectrum Solutions Secures Summary Judgment Win

SALT LAKE CITY--(BUSINESS WIRE)--On May 2, 2023, Spectrum Solutions secured a summary judgment win in a patent infringement suit regarding Spectrum’s groundbreaking whole saliva collection device. Spectrum’s SDNA device became the first product granted Emergency Use Authorization by the Food and Drug Administration for the collection of samples for RT-PCR Covid testing. Soon afterwards, DNA Genotek—a wholly-owned subsidiary of Orasure Tehnologies, Inc.—accused Spectrum of infringing two U.S. pa...
Back to Newsroom